DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the launch of DeviceVue, a comprehensive asset ...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s notice ...
Baxter International Inc. BAX recently announced the launch of comprehensive asset tracking solution DeviceVue. The solution will be used alongside the company’s proprietary pump system, Sigma ...
On April 20, 2022, Rapid7 discovered vulnerabilities in two TCP/IP–enabled medical devices produced by Baxter Healthcare. The flaws, four in total, affected the company’s SIGMA Spectrum Infusion Pump ...
Please provide your email address to receive an email when new articles are posted on . The U.S. Food ad Drug Administration has issued a class 1 recall notice for model 35700 SIGMA Spectrum Infusion ...
The now-recalled versions of both drug-dosing software programs were themselves originally meant to be a fix for Baxter’s last Class I infusion pump recall. In that case, certain versions of Master ...
Leading provider of renal and hospital products cum services, Baxter International, Inc.BAX, announced that its Sigma Spectrum Infusion System was nominated as the best-in-class by a report of the ...
Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results